PATENTS ON PHARMACEUTICAL INVENTIONS IN MEXICO: FROM THE PROHIBITION TO ITS ENHANCEMENT BY USMCA

被引：0
|
作者：
Arcudia Hernandez, Carlos Ernesto [1 ,2 ]
Hernandez Morejon, Veronica [3 ]
机构：
[1] Univ Autonoma San Luis Potosi, San Luis Potosi, San Luis Potosi, Mexico
[2] CONACYT, Sistema Nacl Invest, Mexico City, DF, Mexico
[3] Univ Autonoma San Luis Potosi PNPC CONACYT, Derechos Humanos, San Luis Potosi, San Luis Potosi, Mexico
来源：
REVISTA LA PROPIEDAD INMATERIAL | 2021年 / 31期
关键词：
Medicines; Patents; Trade agreements; Health; Prices;
D O I：
10.18601/16571959.n31.04
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
The pharmaceutical patent granted in Mexico has been part of the process of commercial opening. In parallel, with the incorporation of our country to the free trade agreements the patentability of the pharmaceutical inventions was allowed; the retroactive validity of patents on inventions that were in technical state was stipulated as well as the links of the license to the sanitary register. The negotiation of the Mexico, United States and Canada Trade widened the drug protection, allowing the medical second indication uses and the spreading of patent grants validity due to injustified delays in the convention process.
引用
收藏
页码：103 / 127
页数：25
相关论文
共 50 条
12345